REVRQ · Revlon Inc /De/ - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $468.40M | $442.60M | $479.60M | - | $521.10M | $497.40M | $445.00M | - | $477.10M |
| Cost of Revenue | - | $207.50M | $191.40M | $196.90M | - | $221.20M | $196.30M | $191.20M | - | $234.30M |
| Gross Profit | - | $260.90M | $251.20M | $282.70M | - | $299.90M | $301.10M | $253.80M | - | $242.80M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | $248.50M | $253.00M | $256.90M | - | $256.10M | $279.40M | $260.50M | - | $253.40M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | $27.60M | - | - | - | $33.30M | - | - |
| Operating Income | - | $12.90M | ($29.50M) | $23.70M | - | $34.10M | $14.50M | ($12.70M) | - | ($9.70M) |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | $2.80M | ($500.0K) | $9.80M | - | $5.40M | $7.20M | $11.20M | - | $1.90M |
| Net Income | - | ($152.80M) | ($275.60M) | ($67.00M) | - | ($53.10M) | ($67.70M) | ($96.00M) | - | ($44.50M) |
| EPS - Basic | - | ($2.77) | ($5.00) | ($1.79) | - | ($0.83) | ($2.37) | - | - | - |
| EPS - Diluted | - | ($2.77) | ($5.00) | ($1.79) | - | ($0.98) | ($1.25) | - | - | - |
Balance Sheet
| Line item | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $249.30M | $246.40M | $312.50M | $70.00M | $102.40M | $73.30M | $109.80M | $85.60M | $97.10M | $268.30M |
| Accounts Receivable | $352.70M | $319.00M | $285.30M | $337.80M | $383.80M | $391.30M | $314.30M | $315.60M | $352.30M | $340.80M |
| Inventory | $469.30M | $456.00M | $459.70M | $450.60M | $417.40M | $461.50M | $441.90M | $441.20M | $462.60M | $525.50M |
| Accounts Payable | $125.90M | $105.00M | $80.60M | $263.70M | $217.70M | $245.60M | $197.00M | $195.60M | $203.30M | $219.90M |
| Current Assets | $1.21B | $1.24B | $1.19B | $992.30M | $1.04B | $1.06B | $1.00B | $984.10M | $1.05B | $1.28B |
| Total Assets | $2.49B | $2.52B | $2.50B | $2.37B | $2.43B | $2.45B | $2.42B | $2.43B | $2.53B | $2.97B |
| Current Liabilities | $1.26B | $1.24B | $969.80M | $795.80M | $787.60M | $810.50M | $731.40M | $705.80M | $844.20M | $1.31B |
| Long-term Debt | $100.0K | $100.0K | $0 | $3.31B | $3.31B | $3.30B | $3.30B | $3.27B | $3.10B | $2.93B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | ($2.66B) | ($2.50B) | ($2.35B) | ($2.08B) | ($2.01B) | ($2.07B) | ($2.02B) | ($1.96B) | ($1.86B) | ($1.58B) |
| Retained Earnings | ($3.51B) | ($3.33B) | ($3.18B) | ($2.91B) | ($2.84B) | ($2.85B) | ($2.80B) | ($2.73B) | ($2.63B) | ($2.40B) |
Cash Flow
| Line item | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | $6.70M | - | - | - | ($28.40M) | - | - |
| Investing Cash Flow | - | - | - | ($2.30M) | - | - | - | ($700.0K) | - | - |
| Financing Cash Flow | - | - | - | ($37.60M) | - | - | - | $29.60M | - | - |
| CapEx | - | - | - | $2.30M | - | - | - | $700.0K | - | - |
| Free Cash Flow | - | - | - | $4.40M | - | - | - | ($29.10M) | - | - |
Ratios
| Metric | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 55.7% | 56.8% | 58.9% | - | 57.6% | 60.5% | 57.0% | - | 50.9% |
| Operating margin | - | 2.8% | -6.7% | 4.9% | - | 6.5% | 2.9% | -2.9% | - | -2.0% |
| EBITDA margin | - | - | - | 10.7% | - | - | - | 4.6% | - | - |
| Net margin | - | -32.6% | -62.3% | -14.0% | - | -10.2% | -13.6% | -21.6% | - | -9.3% |
| Free cash flow margin | - | - | - | 0.9% | - | - | - | -6.5% | - | - |
| FCF / Net income | - | - | - | -0.07 | - | - | - | 0.30 | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | 53.1% | 57.2% | 53.6% | - | 49.1% | 56.2% | 58.5% | - | 53.1% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | - | -6.1% | -11.0% | -2.8% | - | -2.2% | -2.8% | -3.9% | - | -1.5% |
| Return on equity | - | 6.1% | 11.7% | 3.2% | - | 2.6% | 3.4% | 4.9% | - | 2.8% |
| Return on invested capital | - | - | - | 1.5% | - | 2.2% | 0.9% | -0.8% | - | -0.6% |
| Liquidity | ||||||||||
| Current ratio | 0.96 | 1.00 | 1.23 | 1.25 | 1.32 | 1.31 | 1.37 | 1.39 | 1.24 | 0.97 |
| Quick ratio | 0.59 | 0.63 | 0.75 | 0.68 | 0.79 | 0.74 | 0.76 | 0.77 | 0.69 | 0.57 |
| Cash ratio | 0.20 | 0.20 | 0.32 | 0.09 | 0.13 | 0.09 | 0.15 | 0.12 | 0.12 | 0.20 |
| Leverage | ||||||||||
| Debt / Equity | -0.00 | -0.00 | 0.00 | -1.59 | -1.64 | -1.60 | -1.63 | -1.67 | -1.67 | -1.85 |
| Debt / Assets | 0.00 | 0.00 | 0.00 | 1.39 | 1.36 | 1.35 | 1.36 | 1.34 | 1.23 | 0.98 |
| Debt / EBITDA | - | - | - | 64.47 | - | - | - | 158.58 | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | -0.94 | -1.01 | -1.07 | -1.14 | -1.21 | -1.18 | -1.20 | -1.24 | -1.36 | -1.88 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | - | 0.19 | 0.18 | 0.20 | - | 0.21 | 0.21 | 0.18 | - | 0.16 |
| Inventory turnover | - | 0.46 | 0.42 | 0.44 | - | 0.48 | 0.44 | 0.43 | - | 0.45 |
| Days sales outstanding | - | 249d | 235d | 257d | - | 274d | 231d | 259d | - | 261d |
| Days inventory outstanding | - | 802d | 877d | 835d | - | 762d | 822d | 842d | - | 819d |
| Days payable outstanding | - | 185d | 154d | 489d | - | 405d | 366d | 373d | - | 343d |
| Cash conversion cycle | - | 866d | 958d | 604d | - | 630d | 686d | 728d | - | 737d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | -10.1% | -11.0% | 7.8% | - | 9.2% | 43.1% | -1.8% | - | -20.1% |
| Revenue CAGR (3y) | - | -7.8% | -8.1% | -5.1% | - | -7.4% | -8.3% | -7.4% | - | -10.5% |
| Revenue CAGR (5y) | - | -6.8% | -7.3% | -4.2% | - | -2.9% | 0.3% | 0.2% | - | 0.2% |
| Gross profit growth (YoY) | - | -13.0% | -16.6% | 11.4% | - | 23.5% | 68.2% | -0.5% | - | -25.9% |
| Operating income growth (YoY) | - | -62.2% | - | - | - | - | - | 93.2% | - | - |
| Net income growth (YoY) | - | -187.8% | -307.1% | 30.2% | - | -19.3% | 46.6% | 55.1% | - | 0.4% |
| EPS growth (YoY) | - | -182.7% | -300.0% | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | 63.4% | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -32.2% | -20.8% | -16.2% | -6.1% | -8.2% | -30.5% | -30.4% | -36.4% | -52.5% | -29.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Business segments
$2.08B totalRevlon Segment$727.90M · 35.0%
Elizabeth Arden Segment$532.30M · 25.6%
Portfolio Segment$419.10M · 20.2%
Fragrances Segment$399.40M · 19.2%
Product / service
$2.08B totalFragrances Segment$580.10M · 27.9%
Color Cosmetics$526.80M · 25.3%
Haircare$472.10M · 22.7%
Skin Care$333.30M · 16.0%
Beauty Care$166.40M · 8.0%
Geographic
$727.90M totalNorth America$389.40M · 53.5%
EMEA$170.60M · 23.4%
Pacific$70.50M · 9.7%
Latin America$57.30M · 7.9%
Asia$40.10M · 5.5%
Peer comparison
Same SIC group: Perfumes, Cosmetics & Other Toilet Preparations
Comparing REVLON INC /DE/ against the 5 most active filers in the same SIC group.